China’s incidence and mortality rates for cancer have been rising year by year, imposing a significant-economic burden on families and society. The "Healthy China Action (2019-2030)" clearly states that cancer prevention should begin as early as possible, regular cancer screenings should be conducted, attention should be paid to cancer-warning signs, and healthy lifestyles should be practiced, with a universal implementation of early cancer screening now a consensus across all sectors.

Precision prevention and control solutions for gastrointestinal tumors comprise comprehensive coverage and multi-cancer coverage looking at the three most common occurrences of such, namely esophageal cancer, gastric cancer, and colorectal cancer. All can be combatted by developing individualized-prevention and control plans through an intelligent risk-assessment platform, joined by professional medical teams and precision, hospital-based multidisciplinary prevention and control centers.

The increase in average life expectancy in China means that cancer has become a chronic disease, while improvements in cancer treatment have also led to rapid growth in market demand for cancer-patient rehabilitation. The Bayzed Health Group targets the needs and pain points of the cancer medical service market, focusing on full-cycle, cancer-medical services and pioneering-clinical practice in cancer rehabilitation in China, including various types of functional rehabilitation, nutritional support, support for advanced malignant tumors, and end-of-life care.

With the aim of optimizing medical scenarios, the Bayzed Health Group focuses on pioneering-medical services and key areas for innovation in the entire-oncology cycle, using the Peking University Medical Innovation Center as a hub to promote the transformation of medical scientific and technological achievements, thus empowering innovation and entrepreneurship.